Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus injectable antibiotic prophylaxis in uncomplicated appendicitis surgery
IRCT20160523028008N12Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metronidazole, cefixime and ceftriaxone in acute appendicitis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Purulent discharge of the wound, Pain at the wound site and 1 more. Started Apr 2021; status: completed.
02
Drugs
metronidazolecefiximeceftriaxone
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on IRCT20160523028008N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160523028008N12.